- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT02532803
Mri IN STaging REctal Polyp Planes (MINSTREL)
Early cancers of the rectum can be removed safely through the anus without subjecting patients to major abdominal surgery in a procedure called TEMS (transanal endoscopic microsurgery). Patients undergoing TEMS can benefit from reduced mortality, impotence, hospital stay and avoiding a stoma that may be associated with pelvic surgery.
Currently few of the patients eligible for TEMS are offered it for a variety of reasons that include uncertainties about the risk of leaving residual tumour and the increased risk of subsequent recurrence of cancer within the pelvis. Current UK guidelines state there is no role for imaging in assessing the malignant polyp. Conversely whilst retrospectively reviewing their MRI databank the investigators have found evidence that MRI can accurately judge the depth of these early tumours and thereby potentially identify patients for local excision.
The investigators hope to prospectively test their hypothesis that an MRI scan can accurately gauge depth of tumour spread in an unselected group of benign and malignant tumours measuring between 20mm and 50mm in size.
The investigators will identify eligible patients awaiting surgery / polypectomy and if they consent to this pilot study participants will undergo an MRI to assess their tumour which assesses safety at all levels of the rectal wall. The accuracy of MRI can then be established by reference to gold standard histopathology. Should MRI prove sensitive and specific then the investigators hope to change national guidelines to mandate MRI to standardise assessment and thereby increase the appropriate use of TEMS in the UK.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
Data published by the NBOCAP in 2014 shows 45% of the 9,433 rectal cancers treated in the UK annually were either T1 or T2 and 66% were node negative. Despite this 77% of those operated on underwent major resection whilst only 11% were locally excised.
Rectal tumours are heterogenous and endosocpic biopsy is an unreliable way to exclude malignancy. Objective endoscopic criteria applied to assess lesion morphology and pit pattern mostly have an evidence base derived from international single centre trials and the accuracy and variable use in UK routine practice remains un-audited. Endorectal ultrasound is rarely used and in routine practice has shown to be inaccurate. Of the early rectal cancers submitted to the UK TEM database, 44% of pT1 and 31% of pT2 cancers were incorrectly presumed to be benign preoperatively. Pre operatively considering a lesion benign when in fact it is malignant is associated with a hazard 1.98 of leaving residual disease after excision with TEMS.
High-Spatial-Resolution magnetic resonance imaging (MRI) is a standard of care in assessing the circumferential resection margin of rectal tumours and triaging patients with more advanced tumours to neoadjuvant therapy to reduce local recurrence. MRI is the established modality for identifying rectal cancer position, the relationship of tumour to the peritoneal reflection, is less user dependent than ultrasound, provides reliable information about extramural disease and is available in all centres that operate on rectal cancer. There is a paucity of evidence base clarifying the current accuracy of MRI in assessing T stage and lymph node involvement in early rectal cancer.
Eligible patients will be identified on colonoscopy if they are found to have a 20mm to 50mm rectal tumour within 150mm of the anal verge. Endoscopic assessment +/- ultrasound +/- biopsies may be taken as per local policy for review at the local multidisciplinary team meeting. Patients will be invited to participate in the trial after the index colonoscopy. Patients will have fully recovered from the endoscopy and any sedation given before being approached to join the trial.
All patients who enter the trial will be sent for an MRI. The MRI will be reported using a novel staging proforma. The results of all the staging investigations, the MRI and any biopsy will be made available to the clinician and any MDT discussion. The patients will proceed to excision or resection of the tumour as per clinician / MDT discussion.
Patients will be followed up as per routine NHS care as determined by local polyp surveillance protocol or MDT discussion.
Studietyp
Inskrivning (Förväntat)
Fas
- Inte tillämpbar
Kontakter och platser
Studieorter
-
-
-
London/Surrey, Storbritannien, SM2 5PT
- Royal Marsden Hospital NHS Foundation Trust
-
-
Croydon
-
Thornton Heath, Croydon, Storbritannien, CR7 7YE
- Croydon University Hospital
-
-
Essex
-
Colchester, Essex, Storbritannien, CO4 5JL
- Colchester General Hospital
-
-
Hampshire
-
Portsmouth, Hampshire, Storbritannien, PO6 3LY
- Queen Alexandra Hospital
-
-
London
-
Isleworth, London, Storbritannien, TW7 6AF
- West Middlesex Hospital
-
-
Oxford
-
Headington, Oxford, Storbritannien, OX3 7LE
- Churchill Hospital
-
-
West Yorkshire
-
Bradford, West Yorkshire, Storbritannien, BD9 6RJ
- Bradford Royal Infirmary
-
-
Wiltshire
-
Salisbury, Wiltshire, Storbritannien, SP2 8BJ
- Salisbury District Hospital
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
- Patients aged over 18 years of age presenting with 20 to 50mm tumours found at flexible sigmoidosocpy /colonoscopy presumed either adenoma or adenocarcinoma.
- Patients must be able to undergo colonoscopy, adequate bowel preparation, MRI, and surgery if necessary.
Exclusion Criteria:
- Patients who are unable to consent, who withhold consent or who withdraw consent will be excluded.
- Patients will be excluded if they have a contraindication to MRI (e.g. intraocular metal fragments, certain pacemakers, severe claustrophobia).
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Diagnostisk
- Tilldelning: N/A
- Interventionsmodell: Enskild gruppuppgift
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
---|---|
Experimentell: Novel pelvic MRI scan assessment
All patients with rectal tumours of 20-50mm in size who consent to enter the trial will receive novel staging report for their pelvic MRI scan.
|
A novel MRI assessment of early rectal cancers will be provided for all patients in MINSTREL
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Tidsram |
---|---|
Measurement of the accuracy of a novel MRI assessment tool to accurately stage Early Rectal Cancers and Polyps
Tidsram: 6 weeks post diagnosis
|
6 weeks post diagnosis
|
Sekundära resultatmått
Resultatmått |
Tidsram |
---|---|
Measurement of Inter-observer Kappa agreement for stage of tumour
Tidsram: At diagnosis
|
At diagnosis
|
Measurement of the Sensitivity and specificity of MRI for lymph node metastasis
Tidsram: 6 weeks after diagnosis
|
6 weeks after diagnosis
|
Samarbetspartners och utredare
Samarbetspartners
Utredare
- Huvudutredare: Gina Brown, Royal Marsden Hospital NHS Foundation Trust
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Faktisk)
Avslutad studie (Förväntat)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
- Matsmältningssystemets sjukdomar
- Neoplasmer
- Neoplasmer efter plats
- Gastrointestinala neoplasmer
- Neoplasmer i matsmältningssystemet
- Gastrointestinala sjukdomar
- Tarmsjukdomar
- Patologiska tillstånd, anatomiska
- Intestinala neoplasmer
- Rektala sjukdomar
- Kolorektala neoplasmer
- Tarmpolyper
- Rektal neoplasmer
- Polyper
- Kolonpolyper
Andra studie-ID-nummer
- CCR4346
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Rektal cancer
-
Institut BergoniéAvslutadMedium och Lower Rectal CancerFrankrike
-
King Faisal Specialist Hospital & Research CenterAvslutadEtt försök med preoperativ kemoradioterapi med capecitabin, strålning och cetuximab vid rektalcancerColon Rectal Cancer Duke Stage StagevalSaudiarabien
-
Abramson Cancer Center of the University of PennsylvaniaAvslutadHuvud- och halscancer | Kolorektal cancer | Mag-tarmcancer | Biopsi bevisad icke småcellig lungcancer | Rectal cancer | Gynekologisk malignitet som kräver definitiv strålbehandlingFörenta staterna
-
University Health Network, TorontoAvslutad
-
Philips HealthcarePhilips Electronics Nederland B.V. acting through Philips CTO organizationAvslutadMalignt lymfom i lymfkörtlarna i inguinalregionen | Malignt lymfom av lymfkörtlar i axillären | Malignt lymfom i lymfkörtlar i livmoderhalsen | Karcinom i parotidkörteln | Colon Rectal Cancer Tubulovillous Adenocarcinoma | Tumör av mjukvävnad i huvud, ansikte och halsNederländerna
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)AvslutadÅterkommande rektalkarcinom | Steg IIIA rektalcancer AJCC v7 | Steg IIIB rektalcancer AJCC v7 | Steg IIIC rektalcancer AJCC v7 | Rektalt mucinöst adenokarcinom | Rectal Signet Ring Cell Adenocarcinom | Steg IIA rektal cancer AJCC v7 | Steg IIB rektalcancer AJCC v7 | Steg IIC rektalcancer AJCC v7Förenta staterna
-
National Cancer Institute (NCI)AvslutadÅterkommande kolonkarcinom | Återkommande rektalkarcinom | Steg IVA tjocktarmscancer | Steg IVA ändtarmscancer | Steg IVB tjocktarmscancer | Steg IVB rektal cancer | Colon mucinöst adenokarcinom | Colon Signet Ring Cell Adenocarcinom | Rektalt mucinöst adenokarcinom | Rectal Signet Ring Cell AdenocarcinomFörenta staterna
-
Stanford UniversityAvslutadGastrointestinala neoplasmer | Bukspottskörtelcancer | Matstrupscancer | Anal cancer | Hepatobiliär neoplasma | Gastroesofageal cancer | Gallblåsa karcinom | Leverkarcinom | Cancer i gallblåsan | Gastrointestinal stromal tumör (GIST) | Carcinom i tjocktarmen | Magcancer | Gallgångskarcinom | Colon Rectal Cancer AdenocarcinomFörenta staterna
-
National Cancer Institute (NCI)AvslutadÅterkommande rektalkarcinom | Steg IIIA rektalcancer AJCC v7 | Steg IIIB rektalcancer AJCC v7 | Steg IIIC rektalcancer AJCC v7 | Steg IVA rektalcancer AJCC v7 | Steg IVB rektalcancer AJCC v7 | Rektalt mucinöst adenokarcinom | Rectal Signet Ring Cell Adenocarcinom | Steg IIA rektal cancer AJCC v7 | Steg IIB... och andra villkorFörenta staterna
-
National Cancer Institute (NCI)AvslutadSteg IIIA rektal cancer | Steg IIIB rektal cancer | Steg IIIC rektal cancer | Återkommande kolonkarcinom | Återkommande rektalkarcinom | Steg IIIA tjocktarmscancer | Steg IIIB Koloncancer | Steg IIIC tjocktarmscancer | Steg IVA tjocktarmscancer | Steg IVA ändtarmscancer | Steg IVB tjocktarmscancer | Steg IVB rektal... och andra villkorFörenta staterna
Kliniska prövningar på Novel Pelvic MRI scan assessment
-
Nantes University HospitalMinistry of Health, FranceAvslutad
-
Jeffrey A. Lieberman, MDAvslutad
-
Lyndra Inc.AvslutadFriska | Alzheimers sjukdom | MagretentionAustralien
-
New York State Psychiatric InstituteNational Institute of Mental Health (NIMH)AvslutadSchizofreniFörenta staterna
-
Massachusetts General HospitalRekryteringBröstcancer | Kemo-hjärna | Försämrad kognitionFörenta staterna
-
The Catholic University of KoreaSaint Vincent's Hospital, KoreaRekrytering
-
Glenn BaumanUnited States Department of Defense; Western University, Canada; Centre for...RekryteringProstatacancer | Prostata Adenocarcinom | Prostata neoplasmKanada
-
Ottawa Hospital Research InstituteCanadian Institutes of Health Research (CIHR)RekryteringArtros | Höftdysplasi | Femoroacetabulär ImpingementKanada
-
Vanderbilt UniversityUniversity of Alberta; Belmont UniversityIndragenFörlamning | RyggmärgsskadaFörenta staterna
-
Ohio State University Comprehensive Cancer CenterPelontoniaAktiv, inte rekryterandeProstatakarcinom | Kardiovaskulär skadaFörenta staterna